Tag Archives: Three Decades

There’s new hope for an overlooked epidemic: Two powerful drugs are nearing the market that promise to help cure many more people of liver-attacking hepatitis C — even though most who have the simmering infection don’t know it yet. Surprisingly, two-thirds of hepatitis C sufferers are thought to be baby boomers who’ve harbored since their younger, perhaps wilder, years a ... Read More »